未登录 分享 收藏
分享 收藏
分享 收藏
Impact of Dose Reductions on Efficacy of Adjuvant Abemaciclib for Patients with High Risk Early Breast Cancer: Analyses from the monarchE Study 剂量减少对高危早期乳腺癌患者辅助阿贝西利（abemaciclib）疗效的影响：monarchE研究分析 Andre, V.; O'Shaughnessy, J.; Cicin, I.; Testa, L.; Tolaney, S.; Huober, J.; Guarneri, V.; Johnston, S.; Martin, M.; Rastogi, P.; Harbeck, N.; Rugo, H.; Wei, R.; Shahir, A.; Goetz, M. 分享 收藏
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer Denkert, Carsten; Schneeweiss, Andreas; Rey, Julia; Karn, Thomas; Hattesohl, Akira; Weber, Karsten E.; Rachakonda, Sivaramakrishna; Braun, Michael; Huober, Jens; Jank, Paul; Sinn, Hans-Peter; Zahm, Dirk-Michael; Felder, Barbel; Hanusch, Claus; Teply-Szymanski, Julia; Marme, Frederik; Fehm, Tanja; Thomalla, Jorg; V. Sinn, Bruno; Stiewe, Thorsten; Marczyk, Michal; Blohmer, Jens-Uwe; van Mackelenbergh, Marion; Schem, Christian; Staib, Peter; Link, Theresa; Muller, Volkmar; Stickeler, Elmar; Stover, Daniel G.; Solbach, Christine; Metzger-Filho, Otto; Jackisch, Christian; Geyer Jr, Charles E.; Fasching, Peter A.; Pusztai, Lajos; Nekljudova, Valentina; Untch, Michael; Loibl, Sibylle 分享 收藏
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer Sinn, Bruno Valentin; Sychra, Katharina; Untch, Michael; Karn, Thomas; van Mackelenbergh, Marion; Huober, Jens; Schmitt, Wolfgang; Marme, Frederik; Schem, Christian; Solbach, Christine; Stickeler, Elmar; Tesch, Hans; Fasching, Peter A.; Schneeweiss, Andreas; Mueller, Volkmar; Holtschmidt, Johannes; Nekljudova, Valentina; Loibl, Sibylle; Denkert, Carsten 分享 收藏
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HRD, HER2L advanced breast cancer: final overall survival results of MONARCH 3 Goetz, M. P.; Toi, M.; Huober, J.; Sohn, J.; Tredan, O.; Park, I. H.; Campone, M.; Chen, S. -C.; Manso, L. M.; Paluch-Shimon, S.; Freedman, O. C.; O'Shaughnessy, J.; Pivot, X.; Tolaney, S. M.; Hurvitz, S. A.; Llombart-Cussac, A.; Andre, V.; Saha, A.; van Hal, G.; Shahir, A.; Iwata, H.; Johnston, S. R. D. 分享 收藏
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer Moebus, Volker; Lueck, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Engels, Knut; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marme, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Theresa; Sinn, Bruno; Janni, Wolfgang; Denkert, Carsten; Seiler, Sabine; Solbach, Christine; Schmatloch, Sabine; Rey, Julia; Loibl, Sibylle 分享 收藏
CDH1 mutations predict resistance to neoadjuvant taxane therapy Knappskog, Stian; Helwa, Reham; Rachakonda, Sivaramakrishna; Gansmo, Liv B.; Denkert, Carsten; Yates, Lucy R.; Solbach, Christine; Untch, Michael; Sinn, Bruno V.; Litmeyer, Anne-Sophie; Ataseven, Beyhan; Huober, Jens; Wedge, David C.; Karn, Thomas; Nikolaienko, Oleksii; Marme, Frederik; Fasching, Peter A.; Eikesdal, Hans Petter; Stickeler, Elmar; Schem, Christian; Jank, Paul; van Mackelenbergh, Marion; Muller, Volkmar; Felder, Baerbel; Holtschmidt, Johannes; Campbell, Peter J.; Loibl, Sibylle; Lonning, Per 分享 收藏
MONARCH 3: Final overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor as first-line therapy for HR+, HER2-advanced breast cancer Goetz, Matthew; Toi, Masakazu; Huober, Jens; Sohn, Joo Hyuk; Tredan, Olivier; Park, Inhae; Campone, Mario; Chen, Shin-Cheh; Manso, Luis Manual; Paluch-Shimon, Shani; Freedman, Orit C.; Andre, Valerie; Saha, Abhijoy; van Hal, Gertjan; Shahir, Ashwin; Iwata, Hiroji; Johnston, Stephen R. D.; O'Shaughnessy, Joyce; Pivot, Xavier; Tolaney, Sara; Hurvitz, Sara; Llombart, Antonio 分享 收藏
Exploring Circulating Leukocyte RNA Expression: Implications for Treatment Outcomes and Immune-Related Adverse Events in Patients with Triple Negative Breast Cancer Enrolled in the GeparNuevo Trial Hubner, Hanna; Ruebner, Matthias; Schneeweiss, Andreas; Denkert, Carsten; Sinn, Hans-Peter; Braun, Michael; Karn, Thomas; Sinn, Bruno V.; Zahm, Dirk-Michael; Thomalla, Jorg; Huober, Jens; Hanusch, Claus; Untch, Michael; Solbach, Christine; Link, Theresa; Filmann, Natalie; Rey, Julia; Holtschmidt, Johannes; Loibl, Sibylle; Fasching, Peter A. 分享 收藏
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in HER2+early-breast cancer (EBC) Fernandez-Martinez, Aranzazu; Tanioka, Maki; Ahn, Sung Gwe; Zagami, Paola; Pascual, Tomas; Rediti, Mattia; Tang, Gong; Hoadley, Katherine A.; Venet, David; Rashid, Naim U.; Spears, Patty; Bliss, Judith; Huober, Jens; Rastogi, Priya; Islam, Md N.; Cortes, Javier; Llombart-Cussac, Antonio; Swain, Sandra; Sotiriou, Christos; Prat, Aleix; Perou, Charles M.; Carey, Lisa 分享 收藏
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) Meyer-Wilmes, P.; Huober, J.; Untch, M.; Blohmer, J. -U.; Janni, W.; Denkert, C.; Klare, P.; Link, T.; Rhiem, K.; Bayer, C.; Reinisch, M.; Bjelic-Radisic, V.; Zahm, D. M.; Hanusch, C.; Solbach, C.; Heinrich, G.; Hartkopf, A. D.; Schneeweiss, A.; Fasching, P.; Filmann, N.; Nekljudova, V.; Holtschmidt, J.; Stickeler, E.; Loibl, S. 分享 收藏
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study Goetz, Matthew P.; Cicin, Irfan; Testa, Laura; Tolaney, Sara M.; Huober, Jens; Guarneri, Valentina; Johnston, Stephen R. D.; Martin, Miguel; Rastogi, Priya; Harbeck, Nadia; Shahir, Ashwin; Wei, Ran; Andre, Valerie; Rugo, Hope S.; O'Shaughnessy, Joyce 分享 收藏
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients Massa, Chiara; Karn, Thomas; Weber, Karsten; Schneeweiss, Andreas; Hanusch, Claus; Blohmer, Jens Uwe; Zahm, Dirk-Michael; Jackisch, Christian; van Mackelenbergh, Marion; Thomalla, Joerg; Marme, Frederik; Huober, Jens; Mueller, Volkmar; Schem, Christian; Mueller, Anja; Stickeler, Elmar; Biehl, Katharina; Fasching, Peter A.; Untch, Michael; Loibl, Sibylle; Denkert, Carsten; Seliger, Barbara 分享 收藏
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer 瑞博西尼联合来曲唑治疗患者的疗效、安全性和预后预测: 激素受体阳性、人表皮生长因子受体-2阴性、局部晚期或转移性乳腺癌3b期RIBECCA研究的最终结果 Fasching, Peter A.; Decker, Thomas; Hartkopf, Andreas; Nusch, Arnd; Heinrich, Bernhard J.; Kurbacher, Christian; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Huober, Jens; Kuemmel, Sherko; Brucker, Sara; Janni, Wolfgang; Schneeweiss, Andreas; Schuler, Martin; Fehm, Tanja; Lueftner, Diana; Quiering, Claudia; Voges, Claudia; Kreuzeder, Julia; Reinisch, Mattea 分享 收藏
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial Fehm, Tanja; Mueller, Volkmar; Banys-Paluchowski, Maggie; Fasching, Peter A.; Friedl, Thomas W. P.; Hartkopf, Andreas; Huober, Jens; Loehberg, Christian; Rack, Brigitte; Riethdorf, Sabine; Schneeweiss, Andreas; Wallwiener, Diethelm; Meier-Stiegen, Franziska; Krawczyk, Natalia; Jaeger, Bernadette; Reinhardt, Florian; Hoffmann, Oliver; Mueller, Lothar; Wimberger, Pauline; Ruckhaeberle, Eugen; Blohmer, Jens-Uwe; Cieslik, Jan-Philipp; Franken, Andre; Niederacher, Dieter; Neubauer, Hans; Pantel, Klaus; Janni, Wolfgang 分享 收藏
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial Schmidt, Marcus; Nitz, Ulrike; Reimer, Toralf; Schmatloch, Sabine; Graf, Heiko; Just, Marianne; Stickeler, Elmar; Untch, Michael; Runnebaum, Ingo; Belau, Antje; Huober, Jens; Jackisch, Christian; Hofmann, Manfred; Krocker, Jutta; Nekljudova, Valentina; Loibl, Sibylle 分享 收藏
Adjuvant abemaciclib plus endocrine therapy for HR+, HER2-, high-risk early breast cancer: Results from a preplanned monarchE overall survival interim analysis, including 5-year efficacy outcomes Harbeck, N.; Rastogi, P.; O'Shaughnessy, J.; Boyle, F.; Cortes, J.; Rugo, H. S.; Goetz, M. P.; Hamilton, E. P.; Huang, C.; Senkus-Konefka, E.; Tryakin, A.; Neven, P.; Huober, J.; Wei, R. J.; Andre, V.; Munoz, M.; Antonio, B. San; Shahir, A.; Jimenez, M. Martin; Johnston, S. R. D. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
Annals of Oncology.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏